Protalix BioTherapeutics (PLX) Net Margin Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,218.00 |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 8,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,693.00 |
| Dec 31, 2025 | -1,002.00 |
| Sep 30, 2025 | 3,867.00 |
| Jun 30, 2025 | 6,346.00 |
| Mar 31, 2025 | -2,157.00 |
| Dec 31, 2024 | 13,668.00 |
| Sep 30, 2024 | 5,365.00 |
| Jun 30, 2024 | 16,054.00 |
| Mar 31, 2024 | -7,082.00 |
| Dec 31, 2023 | -23,778.00 |
| Sep 30, 2023 | 2,431.00 |
| Jun 30, 2023 | 8,440.00 |
| Mar 31, 2023 | -3,942.00 |
| Dec 31, 2022 | -3,805.00 |
| Sep 30, 2022 | 7.00 |
| Jun 30, 2022 | 231.00 |
| Mar 31, 2022 | 5,719.00 |
| Dec 31, 2021 | 23,773.00 |
| Sep 30, 2021 | 80,177.00 |
| Jun 30, 2021 | 24,868.00 |
| Mar 31, 2021 | 11,012.00 |
| Dec 31, 2020 | 58,485.00 |
| Jun 30, 2019 | -5,663.00 |
| Mar 31, 2019 | -6,080.00 |
| Sep 30, 2018 | -100,170.00 |
| Jun 30, 2018 | -50,881.00 |
| Mar 31, 2018 | -19,387.00 |
| Jun 30, 2016 | 29,789.00 |
| Mar 31, 2016 | 11,392.00 |
| Sep 30, 2015 | 31,360.00 |
| Jun 30, 2015 | 4,639.00 |
| Mar 31, 2015 | 18,906.00 |
| Mar 31, 2014 | 1,178.00 |
| Dec 31, 2013 | 96,301.00 |
| Sep 30, 2013 | -15,771.00 |
| Jun 30, 2013 | 58,507.00 |